Correlation between the induction of micronuclei in bone marrow by benzene exposure and the excretion of metabolites in urine of CD-1 mice

Toxicology and Applied Pharmacology
M M Gad-El KarimM S Legator

Abstract

Male and female CD-1 mice received single oral doses of benzene (220, 440, and 880 mg/kg) and were pretreated with modifiers of the mixed-function oxidase enzyme activities. Urinary metabolites (MT) (0-24 and 24-48 hr) were quantified by high-performance liquid chromatography. The micronucleus test was performed at 30 h. The following pretreatments were used to correlate micronucleus formation and the excreted benzene MT: 3-Methylcholanthrene and beta-naphthoflavone led to a marked increase in micronuclei (MN) and MT, whereas phenobarbital caused a slight increase, and SKF-525A had no effect. MN and MT were decreased when benzene was administered by the ip route or toluene was given simultaneously. Females had a lower number of MN and excreted more unconjugated phenol than did males. Muconic acid, hydroquinone, and phenol glucuronide and MN correlated well. They were dependent on both the dose and route of administration of benzene, being most inducible by P-448 inducers, in males more than females. The administration of hydroquinone induced MN, but phenol or catechol (200, 250, and 150 mg/kg, po, respectively) did not, and none of these compounds yielded trans, trans-muconic acid, a benzene MT in urine. This study establishes ...Continue Reading

References

Feb 1, 1975·Mutation Research·W Schmid
Aug 13, 1979·Life Sciences·L S AndrewsJ R Gillette
Jun 1, 1975·CRC Critical Reviews in Toxicology·R Snyder, J J Kocsis
Sep 1, 1986·Archives of Environmental Health·M A Awad el KarimY A el Haimi
Jan 1, 1985·American Journal of Industrial Medicine·E P CronkiteJ E Bullis
Jan 1, 1985·American Journal of Industrial Medicine·M M Gad-el-KarimM S Legator
Mar 1, 1985·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M M Gad-El KarimM S Legator
Sep 30, 1985·Toxicology and Applied Pharmacology·G WitzB D Goldstein
Nov 1, 1970·Toxicology and Applied Pharmacology·L M GonasunR Snyder
Oct 1, 1973·Toxicology and Applied Pharmacology·F U SaitoR Snyder
Sep 1, 1971·Toxicology and Applied Pharmacology·M Ikeda, H Otsuji
May 15, 1981·Biochemical Pharmacology·D P Gill, A E Ahmed
Nov 15, 1984·Biochemical Pharmacology·L GollmerV Ullrich
Jan 1, 1981·Annual Review of Pharmacology and Toxicology·D W NebertA B Okey
Jan 1, 1981·Advances in Experimental Medicine and Biology·R SnyderJ J Kocsis
Jan 1, 1981·Advances in Experimental Medicine and Biology·B D GoldsteinB Wolder
May 1, 1980·Chemico-biological Interactions·R D IronsD E Rickert
Mar 1, 1956·Endocrinology·H E BROWN, T F DOUGHERTY

❮ Previous
Next ❯

Citations

Jan 1, 1995·International Archives of Occupational and Environmental Health·J W PiferJ L O'Donoghue
Jan 1, 1994·Archives of Toxicology·U PlappertH J Seidel
Jun 1, 1994·Mutation Research·D McGregor
Mar 1, 1989·Mutation Research·S J PirozziG F Kalf
May 29, 2004·Mutation Research·John WhysnerElizabeth A Lax
May 31, 2003·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Glenn RitchieDarryl Arfsten
Jul 1, 1989·Environmental Health Perspectives·J E HuffA C Jacobs
Jul 1, 1989·Environmental Health Perspectives·G F KalfS J Pirozzi
Dec 1, 1993·Environmental Health Perspectives·D J PaustenbachP Price
Feb 2, 2010·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Benjamin SmithR Woodrow Setzer
Jun 15, 1988·Toxicology and Applied Pharmacology·P J SabourinR F Henderson
Mar 1, 1990·Toxicology and Applied Pharmacology·C C TravisA D Arms
Nov 22, 2008·Toxicology and Industrial Health·S WilburO Faroon
Feb 12, 2005·Journal of Occupational and Environmental Medicine·William W AuDavid C Christiani
Jan 1, 1994·Critical Reviews in Toxicology·R Snyder, G F Kalf
Dec 17, 1997·Toxicology and Industrial Health·G L Gist, J R Burg
Jan 1, 1992·Archives of Biochemistry and Biophysics·Y C Hsuanyu, H B Dunford

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.